Treatment of Salmonella Bacteremia

Initial Empiric Therapy

• The American College of Physicians recommends combination therapy with ceftriaxone 2g IV once daily plus ciprofloxacin 500-750mg twice daily for bacteremia to prevent initial treatment failure before susceptibility results are available 1, 2
• This dual approach covers potential fluoroquinolone resistance while awaiting culture data 1
• Once susceptibilities are known, de-escalate to single-agent therapy 1

Definitive Monotherapy (After Susceptibility Testing)

• The Centers for Disease Control and Prevention recommends ciprofloxacin 500-750mg twice daily as the preferred fluoroquinolone for susceptible organisms 3, 4
• Ceftriaxone 2g IV once daily is an effective alternative, especially for fluoroquinolone-resistant strains 1
• TMP-SMZ is an alternative if the organism is susceptible 1

Treatment Duration

• The Infectious Diseases Society of America recommends a minimum treatment duration of 14 days for immunocompetent patients 3, 2
• Immunocompromised patients require longer treatment courses, typically 2-6 weeks 2
• HIV-infected patients with bacteremia require long-term suppressive therapy to prevent recurrence 3, 4, 2

Special Populations

HIV/Immunocompromised Patients

• The CDC recommends always treating bacteremia in HIV-infected patients due to the high risk of dissemination 3, 5, 2
• Long-term suppressive therapy with ciprofloxacin is required after initial treatment to prevent recurrence 3, 4

Pregnant Women

• The American College of Obstetricians and Gynecologists recommends avoiding fluoroquinolones entirely 3, 5, 4, 2
• Ceftriaxone, cefotaxime, ampicillin, or TMP-SMZ can be used based on susceptibility 5, 2

Children

• The American Academy of Pediatrics recommends using fluoroquinolones with extreme caution and only if no alternatives exist 3, 5, 4, 2
• Preferred agents include TMP-SMZ, ceftriaxone, cefotaxime, or ampicillin 5, 2

Critical Considerations

• The World Health Organization notes that fluoroquinolone resistance is increasing, particularly in certain serotypes, justifying the initial combination therapy approach until susceptibilities are confirmed 1

Monitoring and Follow-up

• The Infectious Diseases Society of America recommends repeat blood cultures if bacteremia persists to identify undrained foci 6
• Transition to oral therapy (ciprofloxacin 500mg twice daily) is appropriate once clinically improved and bacteremia has cleared 2